Castleman Disease Presenting with Jaundice: A Case with the Multicentric Hyaline Vascular Variant |
Park, Jun-Bean
(Department of Internal Medicine, Seoul National University College of Medicine)
Hwang, Jin-Hyeok (Department of Internal Medicine, Seoul National University College of Medicine) Kim, Hae-Ryoung (Department of Pathology, Seoul National University Bundang Hospital) Choe, Hyung-Sim (Department of Radiology, Seoul National University Bundang Hospital) Kim, Yu-Kyeong (Department of Nuclear Medicine, Seoul National University Bundang Hospital) Kim, Hong-Bin (Department of Internal Medicine, Seoul National University College of Medicine) Bang, Soo-Mee (Departments of Internal Medicine, Seoul National University Bundang Hospital) |
1 | Frizzera G, Peterson BA, Bayrd ED, Goldman A. A systemic lymphoproliferative disorder with morphologic feature of Castleman disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 3:1202-1216, 1985 DOI PUBMED |
2 | Katano H, Sato Y, Kurata T, Mori S, Sata T. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Virology 269:335-344, 2000 DOI ScienceOn |
3 | Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol 129:3-17, 2005 DOI ScienceOn |
4 | Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp130. Blood 86:1243-1254, 1995 PUBMED |
5 | Menke DM, Chadbum A, Cesarman E, Green E, Berenson J, Said J, Tiemann M, Parwaresch R, Thome SD. Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of castleman disease at low risk for HIV infection. Am J Clin Path 117:268-275, 2002 DOI ScienceOn |
6 | Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d'Agay MF, Clauvel JP, Raphael M, Degos L, Sigaux F. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276-1280, 1995 PUBMED |
7 | Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori T. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74:1360-1367, 1989 PUBMED |
8 | Przkora R, Bruns C, Zulke C, Heinkelein J, Rummele P, Schalhorn A, Jauch KW. Castleman disease causing obstructive jaundice. J Hepatol 38:548-549, 2003 DOI ScienceOn |
9 | Al-Salamah SM, Khan IA, Khalid K, Al-Shakweer WA. Castleman disease presenting as obstructive jaundice. Saudi Med J 26:111-113, 2005 |
10 | Casper C, Nichols WG, Huang ML, Corey L, Wald A. Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood 103:1632-1634, 2004 DOI ScienceOn |
11 | Reddy MP, Graham MM. FDG positron emission tomographic imaging of thoracic Castleman disease. Clin Nucl Med 28:325-326, 2003 DOI |
12 | Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 128:657-662, 1998 DOI PUBMED ScienceOn |